Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,823,740 papers from all fields of science
Search
Sign In
Create Free Account
Faslodex
Known as:
Faslodex(ICI 182,780)
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
5 ML fulvestrant 50 MG/ML Prefilled Syringe [Faslodex]
Broader (5)
Antineoplastic Agents
Estradiol
Estrogen Antagonists
ICI 182,780
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A Case Report of Two Primary Cancers, Breast Cancer with Adrenal Gland Metastatic and Second Primary Neuroendocrine Tumor in Colon, a Rare Case in Al-Bashir Hospital
S. Shamoun
,
A. Shamout
2018
Corpus ID: 80313227
A 68 years old female, was diagnosed as a case of right breast cancer in 2013; grade II/III according to Bloom Richardson grading…
Expand
2014
2014
GP 88 ( Progranulin ) Confers Fulvestrant ( Faslodex , ICI 182 , 780 ) Resistance to Human Breast Cancer Cells
Wisit Tangkeangsirisin
,
G. Serrero
2014
Corpus ID: 11499399
The 88 kDa glycoprotein known as GP88, Progranulin or PC cell derived growth factor is an autocrine growth factor with a unique…
Expand
2010
2010
Faslodex 500 a nové možnosti léčby
K. Petráková
2010
Corpus ID: 78416947
Jednim ze zakladnich lecebných postupů u metastatickeho karcinomu prsu je hormonalni lecba. U pacientek s pozitivnimi estrogenov…
Expand
2006
2006
Der Einfluss von 17-β-Estradiol, Tamoxifen und ICI 182,780 (Faslodex) auf die mRNA-Expression der Integrinuntereinheiten α6, β1 und β4 in den Plattenepithelkarzinomzelllinien UM-SCC 14A, 14B und 14C
V. Helmstädter
2006
Corpus ID: 84121331
Titelblatt, Inhalts-, Abbildungs-, Formel-, Tabellen- und Abkurzungsverzeichnis Einleitung Material und Methoden Ergebnisse…
Expand
2005
2005
The nuclear factor K B inhibitor parthenolide restores ICI 182 , 780 ( Faslodex ; fulvestrant ) – induced apoptosis in antiestrogen-resistant breast cancer cells
R. Riggins
,
A. Zwart
,
Ruchi Nehra
,
R. Clarke
2005
Corpus ID: 13522504
The molecular mechanisms underlying the acquisition of resistance to the antiestrogen Faslodex are poorly understood, although…
Expand
2005
2005
SCIENTIFIC DISCUSSION This module reflects the initial scientific discussion for the approval of Faslodex. For information on changes after approval please refer to module 8. 1. Introduction This…
2005
Corpus ID: 4655531
This marketing authorization application concerns Faslodex, solution for injection 250 mg/5ml, which contains the active…
Expand
2004
2004
Distinct effects of the antiestrogen Faslodex on the stability of estrogen receptors-and-in the breast cancer cell line MCF-7
N. T. Peekhaus
,
T. Chang
,
+4 authors
S. Rohrer
2004
Corpus ID: 62890868
The effects of estrogen receptor (ER) ligands on the stability and transcriptional activity of ER in the breast cancer cell lines…
Expand
2004
2004
Fulvestrant (Faslodex®), nouvelle ligne d'hormonothérapie dans les cancers du sein métastatiques
V. Diéras
,
V. Girre
,
J. Pierga
,
P. Cremoux
2004
Corpus ID: 77666928
51 La Lettre du Cancérologue Volume XIII n° 2 mars-avril 2004 L’ hormonothérapie des cancers du sein hormonodépendants a beaucoup…
Expand
2003
2003
SERMs Clomiphene 707 Faslodex 707 Raloxifene 707 Tamoxifen 707 Nonsteroidal Aromatase Inhibitors Anastrozole 711 Letrozole 711
J. Strobl
2003
Corpus ID: 10899853
Biologically important natural estrogens and progestins include estradiol, estrone, estriol, and progesterone. Estradiol-17 is…
Expand
2001
2001
Faslodex for the treatment of breast cancer
Kai Smolnikar
2001
Corpus ID: 78480811
Faslodex (fulvestrant), also known as ICI 182780, is the first in a new class of selective estrogen receptor down-regulators…
Expand